Hi Rose,
If you look at clin trials gov you will find that there are 2 trials for MDS patients where they can receive Promacta for low platelets. One is for patients with advanced MDS - in fact the patients should have more than 20% blast cells which means that they have AML.
The other one is for patients with Low to Int-2 Risk MDS
http://clinicaltrials.gov/ct2/show/N...ombopag&rank=2
Kirby posted this link to GlaxoSmithKline that has discovered Promacta:
http://www.gskforyou.com/16_programs.htm
Kind regards
Birgitta-A